MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 38 filers reported holding MUSTANG BIO INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | – | 278 | +31.1% | 0.00% | – |
| Q4 2022 | $0 | – | 212 | -58.8% | 0.00% | – |
| Q3 2022 | $0 | – | 515 | +347.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 115 | -97.5% | 0.00% | – |
| Q1 2022 | $5,000 | -80.8% | 4,574 | -70.2% | 0.00% | – |
| Q4 2021 | $26,000 | +4.0% | 15,331 | +69.0% | 0.00% | – |
| Q3 2021 | $25,000 | +47.1% | 9,074 | +76.0% | 0.00% | – |
| Q2 2021 | $17,000 | -39.3% | 5,155 | -37.0% | 0.00% | – |
| Q1 2021 | $28,000 | -34.9% | 8,189 | -27.3% | 0.00% | – |
| Q4 2020 | $43,000 | – | 11,260 | +18666.7% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 60 | -94.8% | 0.00% | – |
| Q1 2020 | $3,000 | -50.0% | 1,146 | -27.6% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 1,582 | +16.1% | 0.00% | – |
| Q3 2019 | $4,000 | 0.0% | 1,363 | +101.9% | 0.00% | – |
| Q3 2018 | $4,000 | – | 675 | +4118.8% | 0.00% | – |
| Q2 2018 | $0 | – | 16 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 297,500 | $300,000 | 0.47% |
| GSA CAPITAL PARTNERS LLP | 1,216,445 | $1,229,000 | 0.16% |
| Ikarian Capital, LLC | 546,824 | $551,000 | 0.07% |
| Sassicaia Capital Advisers LLC | 12,000 | $12,000 | 0.06% |
| EMFO, LLC | 32,000 | $32,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 310,926 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 312,800 | $316,000 | 0.01% |
| Renaissance Technologies | 2,449,100 | $2,474,000 | 0.00% |
| Arete Wealth Advisors, LLC | 15,538 | $16,000 | 0.00% |
| Herold Advisors, Inc. | 4,000 | $4,040,000 | 0.00% |